D-Wave Quantum Prepares to Prove Commercial Worth as Cash Reserves Top €884 Million

For years, the quantum computing sector has promised breakthroughs just around the corner. D-Wave Quantum is trying to be the exception — a company that delivers real-world applications, not just research papers. On Thursday, that claim faces its most critical test yet at the Qubits Europe 2026 conference in London, and the company carries a record €884 million cash cushion into the meeting.

The stock climbed 6% on Monday to €21.45, pushing it just above the 200-day moving average of €20.91. The shares have more than doubled from the March low of €11.12, yet they remain 44% below the 52-week high of €38.48 set last October. The relative strength index of 51 signals a market unwilling to commit — pure indecision, as one technician might put it. Over the past month, the stock has gained roughly 15%, but that masks a 10% weekly loss just last week, with annualized 30-day volatility running at 139%. This is not a market for faint hearts.

The transformation from academic experiment to industrial infrastructure is underpinned by D-Wave’s healthiest ever balance sheet. After integrating Quantum Circuits Inc. and completing a restructuring, the company holds more than €884 million in cash and marketable securities. An additional up to $100 million in funding under the CHIPS and Science Act reinforces Washington’s view that D-Wave’s dual-platform strategy — combining quantum annealing with gate-model systems — is strategically important. Many competitors struggle with funding. D-Wave does not.

Yet confidence within the executive suite appears nuanced. CEO Alan Baratz sold roughly $18 million in shares early this month, while CFO John Markovich disposed of over $1 million in equity. The transactions came directly after a sector-wide rally triggered by a major US government quantum initiative. The company describes the sales as tax planning, and Baratz retains a substantial holding, but the optics remain uncomfortable — particularly with a high-stakes investor event looming.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

The London conference is designed to shift the narrative from insider transactions to tangible customer traction. Unlike the investor day D-Wave hosted at the New York Stock Exchange on 1 June, which focused on the product roadmap, Qubits Europe will bring together practitioners and researchers discussing logistics, drug development, and other real-world deployments of D-Wave’s annealing systems. No PowerPoint presentation can match the credibility of a forward-thinking supply chain manager explaining how quantum algorithms are already cutting costs. This is where D-Wave must prove that commercial deployment is more than a hobby.

Wall Street is betting it will. Fifteen analysts rate the stock a strong buy, with a consensus price target of €31.48 — implying roughly 56% upside from Monday’s close. That optimism rests on the Quantum-as-a-Service revenue model and signed contracts such as the €20 million system purchase by Florida Atlantic University. The business model works; the open question is the pace of adoption.

With a market capitalisation of €7.6 billion, D-Wave has outgrown its micro-cap roots. It has liquidity, government backing, and early commercial wins. The London conference will determine whether the stock can hold its ground above the 200-day moving average — or whether the doubters are proved right. On Thursday, the market is waiting for evidence, not promises.